Allianz Asset Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,100
Closed -$370K 2350
2024
Q3
$370K Buy
11,100
+3,400
+44% +$117K ﹤0.01% 1935
2024
Q2
$208K Buy
+7,700
New +$152K ﹤0.01% 2027

Allianz Asset Management's LBPH Position: Q4 2024 in Review

Allianz Asset Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 11,100 shares — an estimated $370K sold.

Allianz Asset Management first reported a position in LBPH in Q2 2024 and held it in 2 quarters. The position peaked at $370K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Allianz Asset Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Allianz Asset Management sold 11,100 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $370K.
  • Allianz Asset Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • Allianz Asset Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $370K in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Allianz Asset Management's 13F filing for Q4 2024, filed 3 Feb 2025.